X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Natco Pharma with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NATCO PHARMA vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 NATCO PHARMA   TEVA PHARMA
EQUITY SHARE DATA
    NATCO PHARMA
Mar-18
TEVA PHARMA
Dec-13
NATCO PHARMA/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,0802,908-   
Low Rs6712,526-   
Sales per share (Unadj.) Rs592.11,669.0-  
Earnings per share (Unadj.) Rs188.4104.3-  
Cash flow per share (Unadj.) Rs206.3239.2-  
Dividends per share (Unadj.) Rs8.2591.27-  
Dividend yield (eoy) %0.93.4 28.0%  
Book value per share (Unadj.) Rs833.61,853.9-  
Shares outstanding (eoy) m36.90848.00-   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x1.51.6 90.8%   
Avg P/E ratio x4.626.1 17.8%  
P/CF ratio (eoy) x4.211.4 37.4%  
Price / Book Value ratio x1.11.5 71.7%  
Dividend payout %4.487.5 5.0%   
Avg Mkt Cap Rs m32,3112,304,126 1.4%   
No. of employees `0004.844.9 10.7%   
Total wages/salary Rs m3,2560-   
Avg. sales/employee Rs Th4,522.531,489.1 14.4%   
Avg. wages/employee Rs Th674.00-   
Avg. net profit/employee Rs Th1,439.01,967.1 73.2%   
INCOME DATA
Net Sales Rs m21,8481,415,276 1.5%  
Other income Rs m4040-   
Total revenues Rs m22,2521,415,276 1.6%   
Gross profit Rs m9,284387,574 2.4%  
Depreciation Rs m662114,398 0.6%   
Interest Rs m15427,798 0.6%   
Profit before tax Rs m8,872245,378 3.6%   
Minority Interest Rs m01,115 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-161,077 0.0%   
Tax Rs m1,920-2,996 -64.1%   
Profit after tax Rs m6,95288,411 7.9%  
Gross profit margin %42.527.4 155.2%  
Effective tax rate %21.6-1.2 -1,772.6%   
Net profit margin %31.86.2 509.4%  
BALANCE SHEET DATA
Current assets Rs m21,307955,872 2.2%   
Current liabilities Rs m5,920833,602 0.7%   
Net working cap to sales %70.48.6 815.2%  
Current ratio x3.61.1 313.9%  
Inventory Days Days7391 80.7%  
Debtors Days Days10796 111.0%  
Net fixed assets Rs m14,986462,260 3.2%   
Share capital Rs m3693,484 10.6%   
"Free" reserves Rs m30,3530-   
Net worth Rs m30,7601,572,104 2.0%   
Long term debt Rs m0723,662 0.0%   
Total assets Rs m37,1513,234,360 1.1%  
Interest coverage x58.69.8 596.4%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.60.4 134.4%   
Return on assets %19.13.6 532.4%  
Return on equity %22.65.6 401.9%  
Return on capital %29.34.9 595.0%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m7,3430-   
CASH FLOW
From Operations Rs m4,636225,522 2.1%  
From Investments Rs m-11,155-79,911 14.0%  
From Financial Activity Rs m6,509-270,529 -2.4%  
Net Cashflow Rs m-18-124,918 0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 69.67 Rs / USD

Compare NATCO PHARMA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare NATCO PHARMA With: FDC LTD.  BIOCON   WYETH LTD  DISHMAN PHARMA  J.B.CHEMICALS  



Today's Market

Sensex Ends 623 Points Higher; Realty and Telecom Stocks Witness Buying(Closing)

Indian share markets ended their day on a strong note today after BJP led NDA government got clear mandate in the Lok Sabha Election 2019.

Related Views On News

NATCO PHARMA Announces Quarterly Results (3QFY19); Net Profit Down 26.7% (Quarterly Result Update)

Feb 14, 2019 | Updated on Feb 14, 2019

For the quarter ended December 2018, NATCO PHARMA has posted a net profit of Rs 2 bn (down 26.7% YoY). Sales on the other hand came in at Rs 6 bn (down 1.0% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

NATCO PHARMA Announces Quarterly Results (2QFY19); Net Profit Up 115.2% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, NATCO PHARMA has posted a net profit of Rs 2 bn (up 115.2% YoY). Sales on the other hand came in at Rs 5 bn (up 27.4% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

My Top 7 Stocks to Profit from Sensex 100,000(The 5 Minute Wrapup)

May 16, 2019

Tanushree Banerjee explains everything you need to know about the Rebirth of India and Sensex 100,000.

3 Stocks to Bet on to Become a 'Dividend Millionaire'(Profit Hunter)

May 14, 2019

As markets continue to rattle amid earning season, upcoming elections, volatile crude price and US China trade war, it's a great idea to add some stability to your portfolio by adding dividend stocks.

Indian Steel: The Perfect Multibagger Opportunity(Profit Hunter)

May 17, 2019

A structurally strong Indian Steel Industry will help India achieve 8%+ GDP growth in the coming years.

What Makes TVS Srichakra and CCL Products a Cut Above the Rest?(The 5 Minute Wrapup)

May 17, 2019

Despite the commodity nature of their businesses, these two stocks have rewarded shareholders well.

The Bitter Pill that Will Lay the Foundation for Sensex 100,000(The 5 Minute Wrapup)

May 14, 2019

These companies will help the Sensex more than double from current levels.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

NATCO PHARMA SHARE PRICE


May 24, 2019 03:33 PM

TRACK NATCO PHARMA

  • Track your investment in NATCO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NATCO PHARMA - BIOCON COMPARISON

COMPARE NATCO PHARMA WITH

MARKET STATS